Literature DB >> 6729771

Antithrombotic activity of a glycosaminoglycan (sulodexide) in rats.

G Andriuoli, R Mastacchi, M Barbanti.   

Abstract

Glycosaminoglycans extracted from various sources are extensively utilized in the treatment of occlusive vascular disease. These products have shown to possess antithrombotic activity in some experimental thrombosis (1,2). Our purpose was to study the activity of Sulodexide, an heparin-like compound (3,4), on rat model of arterial thrombosis and to study its interaction with platelets.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6729771     DOI: 10.1016/0049-3848(84)90108-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.

Authors:  William Brian Reeves; Bishal B Rawal; Emaad M Abdel-Rahman; Alaa S Awad
Journal:  Open J Nephrol       Date:  2012-06-25

2.  Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway.

Authors:  Joseph D Raffetto; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-04-20       Impact factor: 5.858

Review 3.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

4.  Pharmacodynamic Effects of Sulodexide on Profibrinolytic and Haemorrheological Patterns.

Authors:  G L Messa; G La Placa; L Puccetti; A Acciavatti; T Provvedi; E Palazzini; T Di Perri
Journal:  Clin Drug Investig       Date:  1995-09       Impact factor: 2.859

5.  Anti-proteinuric effect of sulodexide in immunoglobulin a nephropathy.

Authors:  Kitae Bang; Ho Jun Chin; Dong Wan Chae; Kwon Wook Joo; Yon Su Kim; Suhnggwon Kim; Kyung Don Ju; Hwajung Kim; Curie Ahn; Kook-Hwan Oh
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

6.  Use of sulodexide in patients with peripheral vascular disease.

Authors:  J Lasierra-Cirujeda; P Coronel; Mj Aza; M Gimeno
Journal:  J Blood Med       Date:  2010-06-15

Review 7.  Development and use of sulodexide in vascular diseases: implications for treatment.

Authors:  Sergio Coccheri; Ferdinando Mannello
Journal:  Drug Des Devel Ther       Date:  2013-12-24       Impact factor: 4.162

8.  Sulodexide attenuates endoplasmic reticulum stress induced by myocardial ischaemia/reperfusion by activating the PI3K/Akt pathway.

Authors:  Danping Shen; Ruiyao Chen; Lijing Zhang; Zhiheng Rao; Yongxue Ruan; Lei Li; Maoping Chu; Yuanhai Zhang
Journal:  J Cell Mol Med       Date:  2019-05-23       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.